Verapamil, a Ca2+ Entry Blocker, Targets the Pore-Forming Subunit of Cardiac Type KATP Channel (Kir6.2)
Journal of Cardiovascular Pharmacology - United States
doi 10.1097/00005344-200308000-00002
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2003
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)